Trial Profile
Non-randomized control study of the evaluation for the switching entecavir to tenofovir alafenamide fumarate in patients with chronic HBV infection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2018
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 May 2018 New trial record